Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mercilon vs NuvaRing in PCOS
NCT01588873Phase 4Unknown
- Sponsor
- University of Oulu
- Start
- Apr 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ethinyl estradiol + desogestrel and etonogestrel + ethinyl estradiol in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of Oulu. Primary endpoint: Change in Matsuda index at 59 weeks. Status: unknown.
02
Drugs
ethinyl estradiol + desogestreletonogestrel + ethinyl estradiol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT01588873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588873.